National Academies Press: OpenBook
« Previous: Attachment A Committee on Continuing Assistance to the National Institutes of Health on Preparation o fAdditional Risk Assessments for the Boston University NEIDL
Suggested Citation:"Attachment B MARCH 19, 2010 OPEN SESSION PUBLIC AGENDA." National Research Council. 2010. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1. Washington, DC: The National Academies Press. doi: 10.17226/12902.
×

Attachment B
MARCH 19, 2010 OPEN SESSION PUBLIC AGENDA

NIH Blue Ribbon Panel to Advise on the Risk Assessment of the National Emerging Infectious Diseases Laboratories at Boston University Medical Center


March 19, 2010


NIH Campus

Building 31, 6thFloor Conference Center, Conference Room 6

Bethesda, Maryland


DRAFT AGENDA

8:30 AM

Welcome and Purpose of Today’s Meeting

Adel Mahmoud, M.D., Ph.D.

Chair, NIH Blue Ribbon Panel

Professor, Department of Molecular Biology, Princeton University

8:35 AM

Opening Remarks

John F. Ahearne, Ph.D., Committee Chair, National Research Council

8:40 AM

Roundtable Introduction of Blue Ribbon Panel and National Research Council Members

8:50 AM

Development of the Supplementary Risk Assessment: Recap of Past Activities and Charting the Course Forward

Adel Mahmoud, M.D., Ph.D.

Amy P. Patterson, M.D., Acting Director, Office of Science Policy, Office of the Director, National Institutes of Health

Karen A. Holbrook, Ph.D., Vice President for Research and Innovation, Office of Research, University of South Florida

Wayne Thomann, Ph.D., Director, Occupational and Environmental Safety and Assistant Research Professor, Duke University/Duke University Medical Center, Nicholas School of the Environment and Earth Sciences

9:40 AM

Accident Sequence Analyses

Ken Bulmahn, Tetra Tech Risk Assessment Team

10:45 AM

Break

Suggested Citation:"Attachment B MARCH 19, 2010 OPEN SESSION PUBLIC AGENDA." National Research Council. 2010. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1. Washington, DC: The National Academies Press. doi: 10.17226/12902.
×

11:00 AM

Health Effects and Transmission Modeling

Adi Gundlapalli, M.D., Ph.D., M.S., Assistant Professor, Departments of Internal Medicine, Pathology and Biomedical Informatics, University of Utah School of Medicine

Damon Toth, Ph.D., Research Assistant Professor, Department of Mathematics, University of Utah

12:30 PM

Break

12:45 PM

Working Lunch and Group Discussion

1:45 PM

Public Comment

2:00 PM

Adjourn

Suggested Citation:"Attachment B MARCH 19, 2010 OPEN SESSION PUBLIC AGENDA." National Research Council. 2010. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1. Washington, DC: The National Academies Press. doi: 10.17226/12902.
×
Page 15
Suggested Citation:"Attachment B MARCH 19, 2010 OPEN SESSION PUBLIC AGENDA." National Research Council. 2010. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1. Washington, DC: The National Academies Press. doi: 10.17226/12902.
×
Page 16
Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1 Get This Book
×
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

In 2003, the Boston University Medical Center (BUMC) was awarded a $128 million grant from the National Institutes of Health to build one of two high- and maximum- containment laboratory facilities for research on biological pathogens. The National Emerging Infectious Disease Laboratories (NEIDL) are meant to support the National Institute of Allergy and Infectious Diseases and biodefense research agenda, conducting research to develop new approaches to treating, preventing, and diagnosing a variety of viral diseases. Diseases and agents to be studied include viruses and bacteria that occur naturally and cause infections or that could be used in deliberate attacks. Continuing Assistance to the National Institutes of Health on Preparation of Additional Risk Assessments for the Boston University NEIDL, Phase 1 reviews the proposed risk assessment plans associated with operating the NEIDL and provides input on key milestones in the development of supplementary risk assessment.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!